Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03298815 · ClinicalTrials.gov registry record · Phase 1
Study for the Treatment of Ocular Chronic Graft-Versus-Host Disease (GVHD) With Amniotic Fluid Eye Drops (AFED)
A Phase 1 study, sponsored by University of Utah.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT03298815 is a Phase 1 study that has completed, run by University of Utah. The registered enrollment target is 15 participants.
The verdict
NCT03298815, a Phase 1 study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
A Randomized, Double-blinded, Placebo-Controlled Study for the Treatment of Ocular Chronic Graft Verses Host Disease with Processed Amniotic Fluid (pAF) Drops.
Interventions
- OTHER Saline Solution
- BIOLOGICAL Amniotic Fluid Eye Drops (AFED)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2019-12-20 |
| Est. Completion | 2023-02-24 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03298815
The ClinicalTrials.gov registry entry for NCT03298815 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline Solution is the first listed.
NCT03298815 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03298815 about?
NCT03298815 is a clinical study titled "Study for the Treatment of Ocular Chronic Graft-Versus-Host Disease (GVHD) With Amniotic Fluid Eye Drops (AFED)". A Randomized, Double-blinded, Placebo-Controlled Study for the Treatment of Ocular Chronic Graft Verses Host Disease with Processed Amniotic Fluid (pAF) Drops.
What is the current status of trial NCT03298815?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2019-12-20. Estimated completion is 2023-02-24.
What interventions are being tested in trial NCT03298815?
The interventions under investigation include: Saline Solution (OTHER), Amniotic Fluid Eye Drops (AFED) (BIOLOGICAL).
Who is sponsoring clinical trial NCT03298815?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.